Salter Robert S, Douglas David, McRobbie Lindsey, Quintana Julio, Legg David, Schwartz Janine, Conaway David, McPhee Carla, Saul Steven, Markovsky Robert
Charm Sciences Inc., 659 Andover St, Lawrence, MA 01843, USA.
J AOAC Int. 2011 Jan-Feb;94(1):348-57.
The Charm 3 SL3 beta-Lactam Test is a 3 min receptor-based lateral-flow Rapid One-Step Assay (ROSA) that detects the six beta-lactam drugs of concern approved for dairy cattle in the United States. The method is a biochemical formulation change of the SL3 beta-Lactam Test evaluated and approved in 2007. The Charm 3 SL3 was evaluated under the AOAC Research Institute Performance Tested Method (PTM) program following the protocol of the U.S. Food and Drug Administration, Center for Veterinary Medicine. The method was approved as PTM 071002 on May 8, 2009. The following drugs were detected in three combined lots: penicillin G at 3.8 ppb, ampicillin at 8.0 ppb, amoxicillin at 8.4 ppb, cephapirin at 20.0 ppb, ceftiofur (total metabolites) at 79 ppb, and cloxacillin at 8.6 ppb > or = 90% of the time with 95% confidence. These detection levels are lower than, but within 75% of, the U.S. Safe Level/Tolerances. Lot-to-lot repeatability was typically within 20% of these determined levels. The test kit was found to be suitable for testing thawed frozen samples. It was also found to respond with equal or better sensitivity to samples that contained incurred analytes, i.e., both the microbiologically active parent drug and its active metabolites. There were no interferences from somatic cells at 1.1 million/mL, bacterial cells at 300 000 CFU/mL, or 32 other non-beta-lactam drugs at 100 ppb. Ruggedness experiments indicated that the test procedure is robust. These results meet the fit-for-purpose approval criteria for inclusion in the National Conference for Interstate Milk Shipments milk testing program.
Charm 3 SL3β-内酰胺检测是一种基于受体的3分钟侧向流动一步法快速检测(ROSA),可检测美国批准用于奶牛的六种β-内酰胺类药物。该方法是2007年评估并批准的SL3β-内酰胺检测的生化配方改进。Charm 3 SL3在美国食品药品监督管理局兽药中心的协议下,根据AOAC研究所性能测试方法(PTM)计划进行了评估。该方法于2009年5月8日被批准为PTM 071002。在三个混合批次中检测到以下药物:青霉素G含量为3.8 ppb、氨苄西林含量为8.0 ppb、阿莫西林含量为8.4 ppb、头孢匹林含量为20.0 ppb、头孢噻呋(总代谢物)含量为79 ppb、氯唑西林含量为8.6 ppb,在95%置信度下,检测时间≥90%。这些检测水平低于美国安全水平/耐受量,但在其75%以内。批次间重复性通常在这些测定水平的20%以内。发现该检测试剂盒适用于检测解冻后的冷冻样品。还发现其对含有内源性分析物的样品具有同等或更好的敏感性,即微生物活性母体药物及其活性代谢物。每毫升110万个体细胞、每毫升30万个CFU细菌细胞或100 ppb的32种其他非β-内酰胺类药物均无干扰。耐用性实验表明该检测程序稳健。这些结果符合纳入州际牛奶运输会议牛奶检测计划的适用性批准标准。